PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

Neuroepithelial tumors represent a heterogeneous class of human tumors including benignant and malignant tumors. The incidence of central nervous system neoplasms ranges from 3.8 to 5.1 cases per 100,000 in the population. Among malignant neuroepithelial tumors, with regard to PPAR ligands, the most...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elisabetta Benedetti, Renato Galzio, Barbara D'Angelo, Maria Paola Cerù, Annamaria Cimini
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2010/427401
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”
by: Elisabetta Benedetti, et al.
Published: (2019-01-01)

Complex Form Variant of Dysembryoplastic Neuroepithelial Tumor of the Cerebellum
by: Jesús Vaquero, et al.
Published: (2012-01-01)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01)

Therapeutic Implications of PPARγ in Human Osteosarcoma
by: Eric R. Wagner, et al.
Published: (2010-01-01)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
by: Rolf Müller, et al.
Published: (2008-01-01)

PPARs and Xenobiotic-Induced Adverse Effects: Relevance to Human Health
by: Christopher Lau, et al.
Published: (2010-01-01)

The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products
by: Mario Umberto Dianzani, et al.
Published: (2008-01-01)

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
by: Graham Skelhorne-Gross, et al.
Published: (2012-01-01)

Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARγ and Identification of TUSC5 Coding Variants in Lean and Obese Humans
by: Trina A. Knotts, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors
by: Lars Tatenhorst, et al.
Published: (2008-01-01)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
by: P. J. Simpson-Haidaris, et al.
Published: (2010-01-01)

PPARs in Neuroinflammation
by: Paul D. Drew, et al.
Published: (2008-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

PPARs and Metabolic Syndrome
by: Lihong Chen, et al.
Published: (2014-01-01)

PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy
by: Chantal Donovan, et al.
Published: (2012-01-01)

Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
by: Kira Vordermark, et al.
Published: (2024-12-01)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
by: Adrienne Bolden, et al.
Published: (2012-01-01)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
by: Neerupma Silswal, et al.
Published: (2012-01-01)

The PPARδ Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells
by: Jordan Clark, et al.
Published: (2009-01-01)

The Role of PPARs in Lung Fibrosis
by: Heather F. Lakatos, et al.
Published: (2007-01-01)

PPARs in Eye Biology and Disease
by: Suofu Qin, et al.
Published: (2008-01-01)

The Functions of PPARs in Aging and Longevity
by: Adnan Erol
Published: (2007-01-01)

PPARs in Alveolar Macrophage Biology
by: Monica R. Smith, et al.
Published: (2007-01-01)

PPAR-δ in Vascular Pathophysiology
by: Nanping Wang
Published: (2008-01-01)

PPARs and Adipose Cell Plasticity
by: Mamen Carmona, et al.
Published: (2007-01-01)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
by: Wojciech G. Garbacz, et al.
Published: (2015-01-01)

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
by: María Sánchez-Aguilar, et al.
Published: (2019-01-01)

Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines
by: G. Martinasso, et al.
Published: (2007-01-01)

PPAR Agonists and Cardiovascular Disease in Diabetes
by: Anna C. Calkin, et al.
Published: (2008-01-01)

PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)

Nutrigenomic Functions of PPARs in Obesogenic Environments
by: Soonkyu Chung, et al.
Published: (2016-01-01)

Coactivators in PPAR-Regulated Gene Expression
by: Navin Viswakarma, et al.
Published: (2010-01-01)

The Role of PPAR Gamma in Systemic Sclerosis
by: Andréa Tavares Dantas, et al.
Published: (2015-01-01)

PPARs: Protectors or Opponents of Myocardial Function?
by: Christine J. Pol, et al.
Published: (2015-01-01)

PPARs in Irradiation-Induced Gastrointestinal Toxicity
by: Christine Linard, et al.
Published: (2010-01-01)

Regulatory role of PPAR in colorectal cancer
by: Cong Wang, et al.
Published: (2025-01-01)

Combined Effects of PPARγ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells
by: Katherine Pegg, et al.
Published: (2013-01-01)

2D-QSAR Analysis of Oxadiazole Substituted α-Isopropoxy phenylpropionic Acids as PPAR-α & PPAR-λ Agonists
by: Soni L. K., et al.
Published: (2004-01-01)

15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
by: Jingjing Li, et al.
Published: (2019-01-01)

PPAR Research: Successful Launching and Promising Future
by: Mostafa Z. Badr
Published: (2009-01-01)